These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26110522)

  • 1. SHEDDING LIGHT ON FUNDUS DRUSEN ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: BREAKING STEREOTYPES OF TYPES I, II, AND III.
    Dalvin LA; Fervenza FC; Sethi S; Pulido JS
    Retin Cases Brief Rep; 2016; 10(1):72-8. PubMed ID: 26110522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.
    Dalvin LA; Fervenza FC; Sethi S; Pulido JS
    Ophthalmology; 2016 Jul; 123(7):1588-94. PubMed ID: 26996341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
    Takei M; Obana A; Inomata T; Tanaka T; Shiang T; Bae Y; Takemura T; Murakami A
    BMC Ophthalmol; 2018 Mar; 18(1):72. PubMed ID: 29510686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal changes associated with type 2 glomerulonephritis.
    McAvoy CE; Silvestri G
    Eye (Lond); 2005 Sep; 19(9):985-9. PubMed ID: 15375355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II).
    Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
    Eur J Ophthalmol; 1991; 1(1):17-22. PubMed ID: 1821193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular impairment during type II membranoproliferative glomerulonephritis].
    Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis.
    Mullins RF; Aptsiauri N; Hageman GS
    Eye (Lond); 2001 Jun; 15(Pt 3):390-5. PubMed ID: 11450763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II].
    Framme C; Herboth T; Roider J; Laqua H
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):252-3. PubMed ID: 9848073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal findings in glomerulonephritis.
    Mack HG; Colville DJ; Harraka P; Savige JA; Invernizzi A; Fraser-Bell S
    Clin Exp Optom; 2022 Jul; 105(5):474-486. PubMed ID: 34877922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
    Gupta N; Wakefield DN; Clapp WL; Garin EH
    Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
    Sethi S; Fervenza FC
    Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T; Ferluga D; Vizjak A; Mraz J; Kojc N
    Diagn Pathol; 2016 Oct; 11(1):94. PubMed ID: 27717365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.
    Sethi S; Nester CM; Smith RJ
    Kidney Int; 2012 Mar; 81(5):434-41. PubMed ID: 22157657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare case of spot diagnosis of nephrotic syndrome in a Saudi male.
    Askar A; Mushtaq F; Al Shuaibi F; Mustafa M; Bappu A
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1003-7. PubMed ID: 21912033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
    Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
    BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
    Noris M; Daina E; Remuzzi G
    Nephrol Dial Transplant; 2023 Feb; 38(2):283-290. PubMed ID: 34596686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive drusen in type I membranoproliferative glomerulonephritis.
    Han DP; Sievers S
    Arch Ophthalmol; 2009 Apr; 127(4):577-9. PubMed ID: 19365045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.